Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Next-generation oral medications in development aim to match injectable efficacy, which would dramatically expand the patient population willing to consider treatment
On the product level, according to Evaluates 2028 projections, Keytruda will maintain its lead at approximately $30 billion, with Mounjaro and Ozempic each reaching about $17 billion
Flexible Commitment Plans are available month-to-month
Additionally, "Guidelines for the Diagnosis and Treatment of Obesity (2024 Edition)" recommended pharmacotherapy when lifestyle interventions fail to meet weight loss goals
Other Telehealth Platforms Elevate Health operates in a market with other telehealth programs also offering GLP-1 access
